يعرض 1 - 10 نتائج من 26 نتيجة بحث عن '"urticaria/si [Side Effect]"', وقت الاستعلام: 0.83s تنقيح النتائج
  1. 1
    مورد إلكتروني

    مصطلحات الفهرس: ademetionine/dt [Drug Therapy], aminotransferase/ec [Endogenous Compound], bile salt export pump/ec [Endogenous Compound], colestyramine/dt [Drug Therapy], cytochrome P450 2D/ec [Endogenous Compound], cytochrome P450 3A4/ec [Endogenous Compound], dexamethasone/dt [Drug Therapy], estradiol/ec [Endogenous Compound], farnesoid X receptor/ec [Endogenous Compound], isoniazid/dt [Drug Therapy], multidrug resistance associated protein 2/ec [Endogenous Compound], multidrug resistance protein 3/ec [Endogenous Compound], progesterone/ec [Endogenous Compound], pyrazinamide/dt [Drug Therapy], rifampicin/ae [Adverse Drug Reaction], rifampicin/cm [Drug Comparison], rifampicin/dt [Drug Therapy], ursodeoxycholic acid/ct [Clinical Trial], ursodeoxycholic acid/cm [Drug Comparison], ursodeoxycholic acid/dt [Drug Therapy], rifampicin/ct [Clinical Trial], adult, article, Australia, bone pain/si [Side Effect], chill/si [Side Effect], controlled study, diarrhea/si [Side Effect], disease severity, drug efficacy, feasibility study, female, fetus hypoxia, fever/si [Side Effect], headache/si [Side Effect], heartburn/si [Side Effect], human, incidence, intrahepatic cholestasis/di [Diagnosis], intrahepatic cholestasis/dt [Drug Therapy], jaundice/si [Side Effect], laboratory test, major clinical study, maternal hypertension, monotherapy, morbidity, mortality, multicenter study, myalgia/si [Side Effect], neonatal intensive care unit, obstetric delivery, parallel design, preeclampsia, pregnancy, pregnancy diabetes mellitus, pregnancy outcome, premature labor, pruritus, quality control, randomized controlled trial, skin disease/si [Side Effect], stillbirth, stomach pain/si [Side Effect], transcription initiation, tuberculosis/dt [Drug Therapy], urticaria/si [Side Effect], vomiting/si [Side Effect], Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28481
    BMC Pregnancy and Childbirth
    Click here for full text options
    LibKey Link

  2. 2
    مورد إلكتروني

    مصطلحات الفهرس: ademetionine/dt [Drug Therapy], aminotransferase/ec [Endogenous Compound], bile salt export pump/ec [Endogenous Compound], colestyramine/dt [Drug Therapy], cytochrome P450 2D/ec [Endogenous Compound], cytochrome P450 3A4/ec [Endogenous Compound], dexamethasone/dt [Drug Therapy], estradiol/ec [Endogenous Compound], farnesoid X receptor/ec [Endogenous Compound], isoniazid/dt [Drug Therapy], multidrug resistance associated protein 2/ec [Endogenous Compound], multidrug resistance protein 3/ec [Endogenous Compound], progesterone/ec [Endogenous Compound], pyrazinamide/dt [Drug Therapy], rifampicin/ae [Adverse Drug Reaction], rifampicin/cm [Drug Comparison], rifampicin/dt [Drug Therapy], ursodeoxycholic acid/ct [Clinical Trial], ursodeoxycholic acid/cm [Drug Comparison], ursodeoxycholic acid/dt [Drug Therapy], rifampicin/ct [Clinical Trial], adult, article, Australia, bone pain/si [Side Effect], chill/si [Side Effect], controlled study, diarrhea/si [Side Effect], disease severity, drug efficacy, feasibility study, female, fetus hypoxia, fever/si [Side Effect], headache/si [Side Effect], heartburn/si [Side Effect], human, incidence, intrahepatic cholestasis/di [Diagnosis], intrahepatic cholestasis/dt [Drug Therapy], jaundice/si [Side Effect], laboratory test, major clinical study, maternal hypertension, monotherapy, morbidity, mortality, multicenter study, myalgia/si [Side Effect], neonatal intensive care unit, obstetric delivery, parallel design, preeclampsia, pregnancy, pregnancy diabetes mellitus, pregnancy outcome, premature labor, pruritus, quality control, randomized controlled trial, skin disease/si [Side Effect], stillbirth, stomach pain/si [Side Effect], transcription initiation, tuberculosis/dt [Drug Therapy], urticaria/si [Side Effect], vomiting/si [Side Effect], Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28481
    BMC Pregnancy and Childbirth
    LibKey Link

  3. 3
    مورد إلكتروني

    مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
    Australasian Journal of Dermatology
    Click here for full text options
    LibKey Link

  4. 4
    مورد إلكتروني

    مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
    Australasian Journal of Dermatology
    LibKey Link

  5. 5
  6. 6
    مورد إلكتروني

    مصطلحات الفهرس: lung disease/si [Side Effect], lung infection/si [Side Effect], maculopapular rash/si [Side Effect], major clinical study, median survival time, mouth inflammation/si [Side Effect], multicenter study, multiple cycle treatment, multiple organ failure/si [Side Effect], nausea/si [Side Effect], neutrophil count, open study, overall survival, pancreatitis/si [Side Effect], patient risk, phase 3 clinical trial, platelet count, pneumonia/si [Side Effect], priority journal, progression free survival, randomized controlled trial, rash/si [Side Effect], renal cell carcinoma/dt [Drug Therapy], side effect/si [Side Effect], skin disease/si [Side Effect], skin exfoliation/si [Side Effect], skin pruritus/si [Side Effect], stomatitis/si [Side Effect], thrombocytopenia/si [Side Effect], thyroiditis/si [Side Effect], urticaria/si [Side Effect], vomiting/si [Side Effect], alanine aminotransferase/ec [Endogenous Compound], aminotransferase/ec [Endogenous Compound], aspartate aminotransferase/ec [Endogenous Compound], bilirubin/ec [Endogenous Compound], creatinine/ec [Endogenous Compound], gamma glutamyltransferase/ec [Endogenous Compound], ipilimumab/ae [Adverse Drug Reaction], ipilimumab/ct [Clinical Trial], ipilimumab/cb [Drug Combination], ipilimumab/cm [Drug Comparison], ipilimumab/dt [Drug Therapy], ipilimumab/iv [Intravenous Drug Administration], nivolumab/ae [Adverse Drug Reaction], nivolumab/ct [Clinical Trial], nivolumab/cb [Drug Combination], nivolumab/cm [Drug Comparison], nivolumab/dt [Drug Therapy], nivolumab/iv [Intravenous Drug Administration], sunitinib/ae [Adverse Drug Reaction], sunitinib/ct [Clinical Trial], sunitinib/cm [Drug Comparison], sunitinib/dt [Drug Therapy], sunitinib/po [Oral Drug Administration], colitis/si [Side Effect], acute kidney failure/si [Side Effect], adrenal insufficiency/si [Side Effect], adult, advanced cancer/dt [Drug Therapy], alanine aminotransferase blood level, anemia/si [Side Effect], aplastic anemia/si [Side Effect], article, aspartate aminotransferase blood level, asthenia/si [Side Effect], bilirubin blood level, blister/si [Side Effect], bronchitis/si [Side Effect], controlled study, creatinine blood level, creatinine clearance, diabetes mellitus/si [Side Effect], diarrhea/si [Side Effect], drug efficacy, drug response, drug safety, drug withdrawal, dysgeusia/si [Side Effect], dyspepsia/si [Side Effect], eczema/si [Side Effect], endocrine disease/si [Side Effect], erythema/si [Side Effect], fatigue/si [Side Effect], gastrointestinal disease/si [Side Effect], gastrointestinal hemorrhage/si [Side Effect], hand foot syndrome/si [Side Effect], heart arrest/si [Side Effect], heart failure/si [Side Effect], hemophagocytic syndrome/si [Side Effect], human, hypertension/si [Side Effect], hyperthyroidism/si [Side Effect], hypertransaminasemia/si [Side Effect], hypophysitis/si [Side Effect], hypopigmentation/si [Side Effect], hypothyroidism/si [Side Effect], interactive voice response system, intermediate risk patient, kidney disease/si [Side Effect], leukocyte count, liver disease/si [Side Effect], liver metastasis/co [Complication], liver metastasis/di [Diagnosis], liver toxicity/si [Side Effect], loss of appetite/si [Side Effect], Article

    URL: The Lancet Oncology
    Click here for full text options
    LibKey Link

  7. 7
  8. 8
    مورد إلكتروني

    مصطلحات الفهرس: lung disease/si [Side Effect], lung infection/si [Side Effect], maculopapular rash/si [Side Effect], major clinical study, median survival time, mouth inflammation/si [Side Effect], multicenter study, multiple cycle treatment, multiple organ failure/si [Side Effect], nausea/si [Side Effect], neutrophil count, open study, overall survival, pancreatitis/si [Side Effect], patient risk, phase 3 clinical trial, platelet count, pneumonia/si [Side Effect], priority journal, progression free survival, randomized controlled trial, rash/si [Side Effect], renal cell carcinoma/dt [Drug Therapy], side effect/si [Side Effect], skin disease/si [Side Effect], skin exfoliation/si [Side Effect], skin pruritus/si [Side Effect], stomatitis/si [Side Effect], thrombocytopenia/si [Side Effect], thyroiditis/si [Side Effect], urticaria/si [Side Effect], vomiting/si [Side Effect], alanine aminotransferase/ec [Endogenous Compound], aminotransferase/ec [Endogenous Compound], aspartate aminotransferase/ec [Endogenous Compound], bilirubin/ec [Endogenous Compound], creatinine/ec [Endogenous Compound], gamma glutamyltransferase/ec [Endogenous Compound], ipilimumab/ae [Adverse Drug Reaction], ipilimumab/ct [Clinical Trial], ipilimumab/cb [Drug Combination], ipilimumab/cm [Drug Comparison], ipilimumab/dt [Drug Therapy], ipilimumab/iv [Intravenous Drug Administration], nivolumab/ae [Adverse Drug Reaction], nivolumab/ct [Clinical Trial], nivolumab/cb [Drug Combination], nivolumab/cm [Drug Comparison], nivolumab/dt [Drug Therapy], nivolumab/iv [Intravenous Drug Administration], sunitinib/ae [Adverse Drug Reaction], sunitinib/ct [Clinical Trial], sunitinib/cm [Drug Comparison], sunitinib/dt [Drug Therapy], sunitinib/po [Oral Drug Administration], colitis/si [Side Effect], acute kidney failure/si [Side Effect], adrenal insufficiency/si [Side Effect], adult, advanced cancer/dt [Drug Therapy], alanine aminotransferase blood level, anemia/si [Side Effect], aplastic anemia/si [Side Effect], article, aspartate aminotransferase blood level, asthenia/si [Side Effect], bilirubin blood level, blister/si [Side Effect], bronchitis/si [Side Effect], controlled study, creatinine blood level, creatinine clearance, diabetes mellitus/si [Side Effect], diarrhea/si [Side Effect], drug efficacy, drug response, drug safety, drug withdrawal, dysgeusia/si [Side Effect], dyspepsia/si [Side Effect], eczema/si [Side Effect], endocrine disease/si [Side Effect], erythema/si [Side Effect], fatigue/si [Side Effect], gastrointestinal disease/si [Side Effect], gastrointestinal hemorrhage/si [Side Effect], hand foot syndrome/si [Side Effect], heart arrest/si [Side Effect], heart failure/si [Side Effect], hemophagocytic syndrome/si [Side Effect], human, hypertension/si [Side Effect], hyperthyroidism/si [Side Effect], hypertransaminasemia/si [Side Effect], hypophysitis/si [Side Effect], hypopigmentation/si [Side Effect], hypothyroidism/si [Side Effect], interactive voice response system, intermediate risk patient, kidney disease/si [Side Effect], leukocyte count, liver disease/si [Side Effect], liver metastasis/co [Complication], liver metastasis/di [Diagnosis], liver toxicity/si [Side Effect], loss of appetite/si [Side Effect], Article

  9. 9
  10. 10